Swiss National Bank - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 203 filers reported holding FIBROGEN INC in Q4 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of FIBROGEN INC
ValueSharesWeighting
Q2 2023$525,960
-85.4%
194,800
+1.1%
0.00%
-100.0%
Q1 2023$3,593,916
+4.3%
192,600
-10.4%
0.00%0.0%
Q4 2022$3,444,300
+25.9%
215,000
+2.3%
0.00%0.0%
Q3 2022$2,735,000
+24.8%
210,200
+1.3%
0.00%
+100.0%
Q2 2022$2,191,000
-7.6%
207,500
+5.2%
0.00%0.0%
Q1 2022$2,372,000
-8.2%
197,300
+7.7%
0.00%
-50.0%
Q4 2021$2,583,000
+38.0%
183,2000.0%0.00%
+100.0%
Q3 2021$1,872,000
-61.1%
183,200
+1.5%
0.00%
-66.7%
Q2 2021$4,807,000
-26.0%
180,500
-3.5%
0.00%
-25.0%
Q1 2021$6,494,000
-4.8%
187,100
+1.7%
0.00%
-20.0%
Q4 2020$6,821,000
-8.8%
183,900
+1.2%
0.01%
-16.7%
Q3 2020$7,476,000
+5.3%
181,800
+3.8%
0.01%0.0%
Q2 2020$7,101,000
+34.2%
175,200
+15.0%
0.01%0.0%
Q1 2020$5,292,000
-17.6%
152,300
+1.7%
0.01%
-14.3%
Q4 2019$6,425,000
+19.1%
149,800
+2.7%
0.01%
+16.7%
Q3 2019$5,395,000
-16.7%
145,900
+1.8%
0.01%
-14.3%
Q2 2019$6,474,000
-14.5%
143,300
+2.8%
0.01%
-12.5%
Q1 2019$7,576,000
+22.0%
139,400
+3.9%
0.01%0.0%
Q4 2018$6,211,000
-22.0%
134,200
+2.4%
0.01%
-11.1%
Q3 2018$7,964,000
-1.8%
131,100
+1.2%
0.01%0.0%
Q2 2018$8,107,000
+44.7%
129,500
+6.8%
0.01%
+28.6%
Q1 2018$5,604,000
+3.3%
121,300
+6.0%
0.01%
+16.7%
Q4 2017$5,423,000
-10.5%
114,400
+1.6%
0.01%
-14.3%
Q3 2017$6,058,000
+89.3%
112,600
+13.6%
0.01%
+75.0%
Q2 2017$3,201,000
+57.2%
99,100
+20.0%
0.00%
+33.3%
Q1 2017$2,036,000
+18.9%
82,600
+3.2%
0.00%0.0%
Q4 2016$1,712,000
+3.4%
80,0000.0%0.00%0.0%
Q3 2016$1,656,000
+26.1%
80,0000.0%0.00%
+50.0%
Q2 2016$1,313,000
-20.1%
80,0000.0%0.00%
-33.3%
Q1 2016$1,643,000
-15.0%
80,000
+26.2%
0.00%
-40.0%
Q4 2015$1,932,000
+41.4%
63,400
+1.8%
0.01%
+25.0%
Q3 2015$1,366,000
+469.2%
62,300
+510.8%
0.00%
+300.0%
Q2 2015$240,00010,2000.00%
Other shareholders
FIBROGEN INC shareholders Q4 2018
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 605,713$9,703,5225.73%
ARMISTICE CAPITAL, LLC 3,864,000$61,901,2801.08%
Logos Global Management LP 525,000$8,410,5000.98%
5AM Venture Management, LLC 225,583$3,613,8400.97%
Intercontinental Wealth Advisors, LLC 191,300$3,064,6260.91%
BHK Investment Advisors, LLC 87,550$1,402,5510.79%
Integral Health Asset Management, LLC 175,000$2,803,5000.59%
Nan Fung Group Holdings Ltd 34,106$546,3780.38%
Soleus Capital Management, L.P. 113,463$1,817,6770.26%
Point72 Asset Management, L.P. 4,781,645$76,601,9530.26%
View complete list of FIBROGEN INC shareholders